ArticleScience advances2019

Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models.

Mandana T Manzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.